US FDA approves Otsuka's blood pressure treatment device for use

Otsuka Holdings

08/11/2023 24:20

Nov 8 (Reuters) - The U.S. Food and Drug Administration
(FDA) approved the use of a device made by an Otsuka Holdings
 4578.T  unit in a type of surgery to treat high blood pressure,
the company said on Wednesday.
    The approval for Paradise Ultrasound Renal Denervation comes
after an FDA panel backed its use. 
    The device is made by Japanese company Otsuka's unit ReCor
and is indicated for use in patients whose hypertension, or high
blood pressure, cannot be controlled with drugs.
    ReCor's device, which is a balloon-like structure inside a
catheter, is inserted through a small cut into the kidney's
arteries and sends ultrasound energy to burn nerves that are
believed to control blood pressure.
    The surgery has been previously approved in Europe and other
parts of the world. 

 (Reporting by Gursimran Kaur in Bengaluru; Editing by
Subhranshu Sahu)
 ((GursimranKaur.Mehar@thomsonreuters.com;))